Approval · Notice of Compliance 10932 · 2010
KEPPRA: Notice of Compliance 10932
Issued January 13, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10932
- Date
- January 13, 2010
- Company
- Ucb Canada IncOakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiepileptic
Products in this notice
Medicinal ingredients
- LEVETIRACETAM 250 MG per TAB
- LEVETIRACETAM 500 MG per TAB
- LEVETIRACETAM 750 MG per TAB